Thomas Emil Andersen

Ph.D.

  • J.B. Winsløws Vej 21, 1.

    5000 Odense C

    Denmark

20042018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Thomas Emil Andersen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Uropathogenic Escherichia coli Medicine & Life Sciences
Biofilms Medicine & Life Sciences
Leucine-2-Alanine Enkephalin Medicine & Life Sciences
Opioid Peptides Medicine & Life Sciences
Prodrugs Medicine & Life Sciences
Dicloxacillin Medicine & Life Sciences
Intestinal Mucosa Medicine & Life Sciences
Growth Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2018

153 Downloads (Pure)

A Method for Quantification of Epithelium Colonization Capacity by Pathogenic Bacteria

Micha Pedersen, R., Grønnemose, R. B., Stærk, K., Antoinette Asferg, C., Bill Andersen, T., Kolmos, H. J., Møller-Jensen, J. & Andersen, T. E., 1. Feb 2018, In : Frontiers in Cellular and Infection Microbiology. 8, FEB, 15 p., 16.

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Epithelium
Endothelium
Virulence
Fluorescence Microscopy
Adhesives

Colonization and biofilm formation by Staphylococcus aureus on endothelial cell layers under flow

Grønnemose, R. B., Antoinette Asferg, C., Kolmos, H. J. & Andersen, T. E., 27. May 2018. 1 p.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Biofilms

Colonization and biofilm formation by Staphylococcus aureus on endothelial cell layers under flow

Grønnemose, R. B., Antoinette Asferg, C., Kolmos, H. J. & Andersen, T. E., 28. May 2018. 1 p.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Biofilms

The impact of inactivation of the purine biosynthesis genes, purN and purT, on growth and virulence in uropathogenic E. coli

Andersen-Civil, A. I. S., Ahmed, S., Guerra, P. R., Andersen, T. E., Hounmanou, Y. M. G., Olsen, J. E. & Herrero-Fresno, A., 30. Oct 2018, In : Molecular Biology Reports. 45, 6, p. 2707–2716

Research output: Contribution to journalJournal articleResearchpeer-review

Uropathogenic Escherichia coli
Virulence
Urine
Growth
Purines

A novel in vitro model for hematogenous spreading of S. aureus device biofilms demonstrating clumping dispersal as an advantageous dissemination mechanism

Grønnemose, R. B., Lindhardt Sæderup (Madsen), K., Kolmos, H. J., Hansen, S., Antoinette Asferg, C., Rasmussen, K. J., Palarasah, Y. & Andersen, T. E., 2017, In : Cellular Microbiology. 19, 12, 13 p., e12785.

Research output: Contribution to journalJournal articleResearchpeer-review

Biofilms
Equipment and Supplies
Phagocytes
In Vitro Techniques
Catheters

Activities 2007 2017

  • 4 Talks and presentations in private or public companies
  • 3 Conference organisation or participation
  • 1 Conference presentations

Danish Microbiological Society Annual Congress 2017

Michael Kemp (Chairman), Hanne Marie Holt (Participant), Thomas Emil Andersen (Participant)
13. Nov 2017

Activity: Attending an eventConference organisation or participation

Modelling Epithelial Infections

Thomas Emil Andersen (Lecturer)
13. Nov 2017

Activity: Talks and presentationsConference presentations

Patogenese ved recidiverende urinvejsinfektion belyst i flowkammermodel

Thomas Emil Andersen (Lecturer)
1. Apr 2016

Activity: Talks and presentationsTalks and presentations in private or public companies

UPEC intracellular pathogenesis pathway in virto: Invasion, fluxing and filamentation studied using a flow chamber-based assay

Thomas Emil Andersen (Lecturer)
1. Nov 2011

Activity: Talks and presentationsTalks and presentations in private or public companies

Metode til kvantificering og undersøgelse af biofilm-dannelse på kateteroverflader

Thomas Emil Andersen (Speaker)
29. Apr 2010

Activity: Talks and presentationsTalks and presentations in private or public companies